EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Vitro Activity of Imipenem-Funobactam Against Clinical Isolates of Gram-Negative Bacilli

James A Karlowsky, Mark G Wise iD, Qifeng Shi, Wenming Zhang, Meijie Le, Jianguo Li iD

Antibiotics · 29.07.2026 · 15 (8) · 733

DOI: 10.3390/antibiotics15080733 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antibiotics, online erschienen am 29.07.2026. Verfasst von James A Karlowsky und 5 weiteren Autor:innen. Beteiligte Einrichtung: IHMA, Schaumburg, IL 60173, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Evopoint Biosciences Co., Ltd..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The intent of this study was to report reference in vitro antimicrobial susceptibility testing results for funobactam (formerly XNW4107) in combination with imipenem against recent, worldwide clinical isolates of Gram-negative bacilli.

Methods

MICs for imipenem in combination with a fixed concentration of funobactam (8 mg/L), and seven comparator agents, were determined using the reference CLSI M07 broth microdilution method for 4003 clinical isolates of Gram-negative bacilli (2008 Enterobacterales, 999 Acinetobacter baumannii, and 996 Pseudomonas aeruginosa) collected from 211 unique clinical laboratory sites in 54 countries as part of industry-sponsored antimicrobial surveillance studies in 2021 and 2022. MICs were interpreted by 2026 CLSI M100 breakpoints. Most isolates with imipenem-funobactam MICs of ≥4 mg/L (95.4%) underwent whole genome sequencing to identify acquired β-lactamase gene carriage.

Results

MIC90 values for imipenem-funobactam were 2 mg/L for all 2008 isolates of Enterobacterales, and 1, 0.5, and 0.5 mg/L, respectively, for metallo-β-lactamase (MBL)-negative Enterobacterales (n = 1969), non-Morganellaceae Enterobacterales (NME) (n = 1752), and MBL-negative NME (n = 1718) isolate subsets. MIC90 values for imipenem-funobactam and imipenem alone were identical or within one doubling dilution for all 14 species of Enterobacterales tested except Klebsiella pneumoniae, Citrobacter freundii, and Enterobacter bugandensis which showed differences of 32-fold (imipenem-funobactam MIC90, 0.5 mg/L; imipenem MIC90, 16 mg/L), 8-fold (0.25 mg/L; 2 mg/L), and 4-fold (0.25 mg/L; 1 mg/L), respectively. Both for all A. baumannii isolates (n = 999) and for MBL-negative isolates (n = 962), the imipenem-funobactam MIC90 value (4 mg/L) was 32-fold lower than for imipenem alone (128 mg/L). Both for all P. aeruginosa (n = 996) isolates and MBL-negative isolates (n = 962), we observed a 4-fold difference in potency between imipenem-funobactam (MIC90, 4 mg/L) and imipenem alone (MIC90, 16 mg/L). Isolates carrying MBL demonstrated the highest MICs for imipenem-funobactam.

Conclusions

Imipenem-funobactam demonstrated potent in vitro activity against most carbapenem-resistant isolates of A. baumannii, K. pneumoniae, NME and many isolates of carbapenem-resistant P. aeruginosa. Continued development of imipenem-funobactam is warranted.

Schlagwörter

Stichwörter der Autor:innen

Gram-negativeXNW4107carbapenem-resistantfunobactamimipenem

Autor:innen und Institutionen

  • IHMA, Schaumburg, IL 60173, USA.
  • Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB R3E 3J7, Canada.
  • Evopoint Biosciences Co., Ltd., Suzhou 215000, China.

ORCID-Profile: Mark G Wise, Jianguo Li

Förderung

  • Evopoint Biosciences Co., Ltd.

Zitieren

APA

Karlowsky, J. A., Wise, M. G., Shi, Q., Zhang, W., Le, M., & Li, J. (2026). In Vitro Activity of Imipenem-Funobactam Against Clinical Isolates of Gram-Negative Bacilli. Antibiotics, 15(8), 733. https://doi.org/10.3390/antibiotics15080733

Vancouver

Karlowsky JA, Wise MG, Shi Q, Zhang W, Le M, Li J. In Vitro Activity of Imipenem-Funobactam Against Clinical Isolates of Gram-Negative Bacilli. Antibiotics. 2026;15(8):733. doi:10.3390/antibiotics15080733

BibTeX
@article{Karlowsky2026,
  author = {Karlowsky, James A and Wise, Mark G and Shi, Qifeng and Zhang, Wenming and Le, Meijie and Li, Jianguo},
  title = {In Vitro Activity of Imipenem-Funobactam Against Clinical Isolates of Gram-Negative Bacilli},
  journal = {Antibiotics},
  year = {2026},
  volume = {15},
  number = {8},
  pages = {733},
  doi = {10.3390/antibiotics15080733}
}
Kostenlos starten →